95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.48%
Revenue growth at 50-75% of FNV's 21.32%. Martin Whitman would worry about competitiveness or product relevance.
34.24%
Gross profit growth at 75-90% of FNV's 39.74%. Bill Ackman would demand operational improvements to match competitor gains.
61.16%
EBIT growth below 50% of FNV's 563.79%. Michael Burry would suspect deeper competitive or cost structure issues.
61.16%
Operating income growth under 50% of FNV's 514.51%. Michael Burry would be concerned about deeper cost or sales issues.
739.91%
Net income growth above 1.5x FNV's 308.31%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
766.67%
EPS growth above 1.5x FNV's 305.88%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
766.67%
Diluted EPS growth above 1.5x FNV's 305.88%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reduction while FNV stands at 9.91%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
8.97%
OCF growth under 50% of FNV's 46.83%. Michael Burry might suspect questionable revenue recognition or rising costs.
9.36%
FCF growth under 50% of FNV's 145.65%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
264.31%
10Y revenue/share CAGR 1.25-1.5x FNV's 191.21%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
9.44%
5Y revenue/share CAGR under 50% of FNV's 35.96%. Michael Burry would suspect a significant competitive gap or product weakness.
8.83%
3Y revenue/share CAGR under 50% of FNV's 21.50%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
210.93%
10Y OCF/share CAGR at 75-90% of FNV's 262.10%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
-17.22%
Negative 5Y OCF/share CAGR while FNV is at 77.73%. Joel Greenblatt would question the firm’s operational model or cost structure.
-5.79%
Negative 3Y OCF/share CAGR while FNV stands at 29.25%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
130.83%
Below 50% of FNV's 821.01%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-42.21%
Negative 5Y net income/share CAGR while FNV is 44.98%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
26.90%
Below 50% of FNV's 93.86%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
180.93%
10Y equity/share CAGR above 1.5x FNV's 78.22%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
22.48%
5Y equity/share CAGR at 75-90% of FNV's 25.21%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
14.01%
3Y equity/share CAGR above 1.5x FNV's 2.02%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-16.61%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
0.13%
Asset growth well under 50% of FNV's 1.49%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
1.04%
50-75% of FNV's 1.59%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-6.01%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-22.36%
We cut SG&A while FNV invests at 32.69%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.